Format

Send to

Choose Destination
Nat Med. 2018 Nov;24(11):1773-1775. doi: 10.1038/s41591-018-0094-7.

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.

Author information

1
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. kriegc@musc.edu.
2
Department of Microbiology and Immunology and Department of Dermatology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA. kriegc@musc.edu.
3
Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
4
Swiss Institute of Bioinformatics (SIB), University of Zurich, Zurich, Switzerland.
5
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
6
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
7
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
8
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. mitchell.levesque@usz.ch.
9
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. becher@immunology.uzh.ch.

Abstract

In the version of this article initially published, Figs. 5a,c and 6a were incorrect because of an error in a metadata spreadsheet that led to the healthy donor patient 2 (HD2) samples being used twice in the analysis of baseline samples and in the analysis at 12 weeks of anti-PD-1 therapy, while HD3 samples had not been used.

PMID:
29967347
DOI:
10.1038/s41591-018-0094-7

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center